🚨Registration is open for #EASD2026! Join us in Milan or virtually from 28 Sept - 2 Oct 2026 for the 62nd EASD #Annual#Meeting!
✅ In-person & virtual access
✅ Networking & industry insights
✅ Preferential hotel rates for delegates
👉Register now: https://t.co/23j2EsVZWj
🎙️How should CGM be used in T2D? Dame @profmjdavies & @DrAmandaAdler discuss a new EASD guideline, exploring evidence, how future recommendations shape diabetes care & policy.
To be 1st presented at #EASD2026 Milan:
📅30 Sept |🕛16:30 |📍London Hall
🎧👉 https://t.co/PIyXuwTybq
👏🎉Congrats to EASD Honorary Member Bernard Zinman,MDCM, inducted into the @CdnMedHallFame's Class of 2026. A pioneer in diabetes research & care, his landmark clinical trials have shaped treatment standards & improved outcomes for PLWD. A well-deserved honour!
- EASD Community
Congratulations to our long-standing EASD members honoured with 2026 @AmDiabetesAssn National Scientific & Health Care Achievement Awards:
🏆Chantal Mathieu, Naveed Sattar, Timo Müller & Gerald Shulman.
Recognised for outstanding contributions to #diabetes#research & care.
What are the most exciting new trial data re #incretin-based therapies?
What’s new in the 2026 @AmDiabetesAssn EASD Consensus Report on the Management of #T2D?
EASD President Francesco Giorgino, Prof. Naveed Sattar & Prof. @AliceYYCheng wrap it up!
📺https://t.co/29JgriSg8N
🧠Meet Dr. Ben A. Kappel recipient of the #EFSD & @Sanofi European Diabetes Research Programme in #CVD. 👏
He investigates how #T2D alters cardiac #metabolism & contributes to heart failure with preserved ejection fraction (HFpEF).
📄 Under preparation
💡 https://t.co/Q5EOaFNmin
🎉 Congrats to EASD member, @profmjdavies on being named a Dame Commander of the Order of the British Empire (DBE) in The King's Birthday Honours List! A well-deserved honour for her extraordinary global contributions to #T2D research.
📖👉https://t.co/CQrDv3272E
We’re proud to share our Co-Director, @profmjdavies, has been awarded a DBE in the #KingsBirthdayHonours for her outstanding contribution to global diabetes research, policy & care.
Congratulations from all of us!
Read more: https://t.co/x3uc7AjKae
2️⃣days left to submit your Late Breaking Abstracts! To be considered, your #abstract must present new information not yet known/fully available at the time of the first #submission.
Submission deadline: 📅 17 June 2026 | 🕛 18:00 CEST
Learn more 👉 https://t.co/Rwh0aVsXjF
🔬 📢 1 week left to submit your Late Breaking Abstracts! The LBA submission window is still open for truly novel research.❗❗New findings with high scientific significance!
Submit before: 📅 17 June 2026 | 🕛 18:00 CEST
Learn more👉 https://t.co/Rwh0aVsXjF
🪙50 years after attending his 1st EASD Annual Meeting, Prof. Eberhard Standl (@HelmholtzMunich) reflects on the evolution of diabetes care - from diabetic ketoacidosis & early #T1D to diabetes remission, cancer links & the future of cure.
🎧👉Listen now: https://t.co/PIyXuwTybq
We, @EASDnews & @AmDiabetesAssn are requesting public commentary on the 2026 Consensus Report on the Management of #Type2Diabetes.
📅 Review the symposium slides & submit your input before 11:59 pm ET (17:59 CEST) on 16 June 2026.
👉🔗 https://t.co/bCUu1foayg
📢Applications are open for the #EFSD & @LillyDiabetesIn European Diabetes Research Programme! Supporting innovative basic & clinical #diabetes#research across EU & associated countries.
📅Deadline: 1 Sept 2026
Submit via the EFSD Programme Portal 👉 https://t.co/dFdUeAQD8E
🏆 We're honoured to announce Prof. Jens Holst as the recipient of the 2nd EASD Diabetes Global Impact Prize 2026! His contributions to the discovery of GLP-1 & its therapeutic potential has transformed #diabetes & #obesity care🌎.
🔗👉 https://t.co/colZC2Y5tH
@LillyDiabetesIn
🔬 📢 1 week left to submit your Late Breaking Abstracts! The LBA submission window is still open for truly novel research.❗❗New findings with high scientific significance!
Submit before: 📅 17 June 2026 | 🕛 18:00 CEST
Learn more👉 https://t.co/Rwh0aVsXjF
Are #MASLD & #MASH are only liver complications? No, they are #metabolic complications, points out @DidacMauricio. He co-chaired an #EASL/#EASD joint session focused on screening, referral & treatment for people with #T2D & fibrotic #MASH. Watch it now: https://t.co/9Gsdc4oQQr
🧠Meet Dr Emma Ahlqvist, recipient of the #EFSD "New Targets for #Diabetes/#Obesity-related Metabolic Diseases" grant. Her research combines genomics & 3D human muscle organoids to identify new pathways driving diabetes & insulin resistance.
📄Stay tuned
💡https://t.co/HxiDITK6DI
📖 Our next @EASDacademy webinar features EiC Dr. Jennifer Sargent & Assoc. Editor & @EASDacademy committee member Dr. Simon Dreher, who'll walk you through the journal's vision & how to get involved
📅 2 July 2026 | 🕛 16:00 CEST
🔗👉 Register now: https://t.co/FORbtlQkU7
📺 Join EIC Jennifer Sargent & Assoc. Editor @SimonDreher1 for a webinar introducing EASD’s new journal, @MetabologiaJnl.
Learn about its vision, scope, submissions, & editorial opportunities for early-career researchers.
📅 2 Jul 2026 | 16:00 CEST
🔗👉https://t.co/gqqHVHhykV
🌏 Science knows no borders. The #EFSD/#JDS Reciprocal Travel Research Fellowship is still open for applications.
✅Open to applicants from Japan 🇯🇵/ Europe🇪🇺
📅 Deadline: 1 July 2026 | 🕛 12:00 CEST
🔗👉 Apply now: https://t.co/dN3eDohaFt
#Diabetes#Research#Fellowship
🎙️What’s new in the updated #EASD-@ADA_DiabetesPro Consensus Report on #T1D?
Profs @RichardIGHolt & Kirsten Nørgaard discuss #CGM as the gold standard, automated insulin delivery, obesity management & #diabetes complications.
🎧 Listen now - https://t.co/PIyXuwTybq